Satellos Bioscience Inc. (MSLE)

Satellos Bioscience will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Satellos Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	-	6.04	4.87
Research & Development	-	14.36	6.46
Operating Expenses	-	20.4	11.33
Operating Income	-24.49	-20.4	-11.33
Interest Expense (Income)	-	-1	-0.85
Other Expense (Income)	-2.46	1.24	1.16
Pretax Income	-22.03	-20.63	-11.64
Net Income	-22.03	-20.63	-11.64
Free Cash Flow	-21.56	-18.26	-8.5
EBITDA	-22.01	-21.62	-12.48
Depreciation & Amortization	0.01	0.02	0.01
EBIT	-22.03	-21.64	-12.49

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).